Meric-Bernstam F - Search Results

1

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.

Meric-Bernstam F, Makker V, Oaknin A, Oh DY, Banerjee S, González-Martín A, Jung KH, Ługowska I, Manso L, Manzano A, Melichar B, Siena S, Stroyakovskiy D, Fielding A, Ma Y, Puvvada S, Shire N, Lee JY. Meric-Bernstam F, et al. J Clin Oncol. 2024 Jan 1;42(1):47-58. doi: 10.1200/JCO.23.02005. Epub 2023 Oct 23. J Clin Oncol. 2024. PMID: 37870536 Free PMC article. Clinical Trial.

2

Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.

Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TA. Chen AM, et al. J Clin Oncol. 2004 Jun 15;22(12):2303-12. doi: 10.1200/JCO.2004.09.062. J Clin Oncol. 2004. PMID: 15197191

3

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.

Mazouni C, Peintinger F, Wan-Kau S, Andre F, Gonzalez-Angulo AM, Symmans WF, Meric-Bernstam F, Valero V, Hortobagyi GN, Pusztai L. Mazouni C, et al. J Clin Oncol. 2007 Jul 1;25(19):2650-5. doi: 10.1200/JCO.2006.08.2271. J Clin Oncol. 2007. PMID: 17602071

4

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.

Yao JC, Phan AT, Chang DZ, Wolff RA, Hess K, Gupta S, Jacobs C, Mares JE, Landgraf AN, Rashid A, Meric-Bernstam F. Yao JC, et al. J Clin Oncol. 2008 Sep 10;26(26):4311-8. doi: 10.1200/JCO.2008.16.7858. J Clin Oncol. 2008. PMID: 18779618 Free PMC article. Clinical Trial.

5

Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.

Dawood S, Broglio K, Kau SW, Green MC, Giordano SH, Meric-Bernstam F, Buchholz TA, Albarracin C, Yang WT, Hennessy BT, Hortobagyi GN, Gonzalez-Angulo AM. Dawood S, et al. J Clin Oncol. 2009 Jan 10;27(2):220-6. doi: 10.1200/JCO.2008.17.9952. Epub 2008 Dec 1. J Clin Oncol. 2009. PMID: 19047281 Free PMC article.

6

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.

Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM. Jiralerspong S, et al. J Clin Oncol. 2009 Jul 10;27(20):3297-302. doi: 10.1200/JCO.2009.19.6410. Epub 2009 Jun 1. J Clin Oncol. 2009. PMID: 19487376 Free PMC article.

7

High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.

Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN. Gonzalez-Angulo AM, et al. J Clin Oncol. 2009 Dec 1;27(34):5700-6. doi: 10.1200/JCO.2009.23.2025. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884543 Free PMC article.

8

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes.

Mittendorf EA, Wu Y, Scaltriti M, Meric-Bernstam F, Hunt KK, Dawood S, Esteva FJ, Buzdar AU, Chen H, Eksambi S, Hortobagyi GN, Baselga J, Gonzalez-Angulo AM. Mittendorf EA, et al. Clin Cancer Res. 2009 Dec 1;15(23):7381-8. doi: 10.1158/1078-0432.CCR-09-1735. Epub 2009 Nov 17. Clin Cancer Res. 2009. PMID: 19920100 Free PMC article.

9

Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.

Caudle AS, Gonzalez-Angulo AM, Hunt KK, Liu P, Pusztai L, Symmans WF, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Caudle AS, et al. J Clin Oncol. 2010 Apr 10;28(11):1821-8. doi: 10.1200/JCO.2009.25.3286. Epub 2010 Mar 15. J Clin Oncol. 2010. PMID: 20231683 Free PMC article.

10

Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer.

Hernandez-Aya LF, Chavez-Macgregor M, Lei X, Meric-Bernstam F, Buchholz TA, Hsu L, Sahin AA, Do KA, Valero V, Hortobagyi GN, Gonzalez-Angulo AM. Hernandez-Aya LF, et al. J Clin Oncol. 2011 Jul 1;29(19):2628-34. doi: 10.1200/JCO.2010.32.1877. Epub 2011 May 23. J Clin Oncol. 2011. PMID: 21606433 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

672 results

Search Page